share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施贵宝 | 4:持股变动声明
SEC announcement ·  04/02 18:46
Moomoo AI 已提取核心信息
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has engaged in a transaction involving the company's stock on March 31, 2024. The details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and the transaction's status, whether it was a purchase or sale, is also not provided in the available information.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has engaged in a transaction involving the company's stock on March 31, 2024. The details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and the transaction's status, whether it was a purchase or sale, is also not provided in the available information.
菲利斯·耶鲁,百时美施贵宝公司的举报人[BMY] 于2024年3月31日进行了一笔涉及公司股票的交易。该交易的细节,包括股票数量、股票性质、交易价格和股票总价值,尚未在公告中披露。没有具体说明耶鲁与发行人的关系,现有信息中也没有提供该交易的状态,无论是买入还是出售。
菲利斯·耶鲁,百时美施贵宝公司的举报人[BMY] 于2024年3月31日进行了一笔涉及公司股票的交易。该交易的细节,包括股票数量、股票性质、交易价格和股票总价值,尚未在公告中披露。没有具体说明耶鲁与发行人的关系,现有信息中也没有提供该交易的状态,无论是买入还是出售。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息